Sun Pharmaceutical Industries, Inc. Issues Nationwide Voluntary Recall of One Lot of Nimodipine Capsules due to Crystallization of the Fill Material

by FDA on September 4, 2012

in FDA Recalls,Food Recalls

Sun Pharmaceutical Industries, Inc. (Sun Inc) announced today that it is voluntarily recalling from users one lot of Nimodipine Capsules, 30 mg, marketed by Caraco Pharmaceutical Laboratories, Ltd. Sun Inc. commenced the recall as a precautionary measure due to the presence of crystals of nimodipine within the capsule solution of this lot as identified by a customer complaint. No adverse events have been reported at this time.

This is a summary of a recall issued by the Food and Drug Administration (FDA). The link below will take you to the original recall press release containing complete information, including instructions about what to do if you are affected by this recall.

View Full Details Of Original FDA Recall Notice Here.

Leave a Comment

Previous post:

Next post: